Is this company the biggest dark horse in the chronic weight management space?

Estuary Biotherapeutics has swum out of stealth with $103 million in funding to power a pair of gene therapies into clinical ...

Two new biotechnology majors have been introduced by QUT in recognition of its critical role in addressing some of the world's most pressing current ...

Dr Villoo Morawala Patell, founder of Avesthagen and Avestagenome Project International, discusses how India can turn its ...

I see the risk-reward as favorable, with a strong balance sheet, upgraded guidance, and multiple expansion potential driven by new product commercialization. NovoCure describes their mission as ...

Raising funding, assembling the initial team, building lab operations from the ground up, generating proof-of-concept ...

The business provides AI-enabled data intelligence and decision-support tools for R&D and commercialization to the ...

Vir Biotechnology (NASDAQ:VIR) advances dual-masked T-cell engagers and hepatitis programs as a busy clinical calendar draws attention.

Meet Zach Frankel, the secretive investor behind Cognition, Ramp• Why techies are hoarding AI compute in their homes• Plus, Recommendations—our weekly pop culture picks: “Bram Stoker’s Dracula,” “The ...

This is a story from a little while ago. I applied for the IPO lottery. An IPO is when a company lists its shares on the stock market for the first time.akippa: Failed to win. Skyfall: Failed to ...

Robust long-term knowledge and capability accumulation lays a solid foundational framework for driving extraordinary, ...